Viewing StudyNCT06436183



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06436183
Status: RECRUITING
Last Update Posted: 2024-05-30
First Post: 2024-04-09

Brief Title: A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Sponsor: Apollo Therapeutics Ltd
Organization: Apollo Therapeutics Ltd

Conditions & Keywords Data

Conditions:
Name
Atopic Dermatitis
Atopic
Dermatitis
Dermatologic Disease
Eczema
Eczema Atopic Dermatitis
Eczema Atopic
Keywords: